Hologic, Inc. (NASDAQ: HOLX) is 5.44% higher on its value in year-to-date trading and has touched a low of $64.02 and a high of $87.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HOLX stock was last observed hovering at around $76.33 in the last trading session, with the day’s loss setting it -0.99%.
Currently trading at $75.34, the stock is 0.44% and 1.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.73 million and changing -1.30% at the moment leaves the stock 2.06% off its SMA200. HOLX registered -5.07% loss for a year compared to 6-month gain of 4.58%. The firm has a 50-day simple moving average (SMA 50) of $4.62 and a 200-day simple moving average (SMA200) of $17.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.83% loss in the last 1 month and extending the period to 3 months gives it a 7.63%, and is -1.28% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.58% over the week and 1.68% over the month.
Hologic, Inc. (HOLX) has around 6990 employees, a market worth around $17.68B and $3.97B in sales. Current P/E ratio is 35.82 and Fwd P/E is 17.10. Profit margin for the company is 12.98%. Distance from 52-week low is 17.68% and -14.27% from its 52-week high. The company has generated returns on investments over the last 12 months (7.16%).
Hologic, Inc. quarterly earnings per share for the current quarter are estimated at $0.98 with sales reaching $1B over the same period.The EPS is expected to grow by 1.88% this year, but quarterly earnings will post -0.00% year-over-year.
1,108 institutions hold shares in Hologic, Inc. (HOLX), with institutional investors hold 100.16% of the company’s shares. The shares outstanding are 241.71M, and float is at 231.14M with Short Float at 2.37%. Institutions hold 99.41% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 28.5 million shares valued at $2.31 billion. The investor’s holdings represent 11.64% of the HOLX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 23.85 million shares valued at $1.93 billion to account for 9.74% of the shares outstanding. The other top investors are T. Rowe Price Investment Management, Inc. which holds 21.94 million shares representing 8.96% and valued at over $1.78 billion, while State Street Corporation holds 4.71% of the shares totaling 11.54 million with a market value of $934.62 million.
Hologic, Inc. (HOLX) Insider Activity
The most recent transaction is an insider sale by CRAWFORD SALLY, the company’s Director. SEC filings show that CRAWFORD SALLY sold 9,039 shares of the company’s common stock on Mar 08 ’24 at a price of $76.40 per share for a total of $0.69 million. Following the sale, the insider now owns 0.13 million shares.
Hologic, Inc. disclosed in a document filed with the SEC on Mar 08 ’24 that Dockendorff Charles J (Director) sold a total of 1,465 shares of the company’s common stock. The trade occurred on Mar 08 ’24 and was made at $76.21 per share for $0.11 million. Following the transaction, the insider now directly holds 1572.0 shares of the HOLX stock.
Still, SEC filings show that on Jan 29 ’24, Oberton Karleen Marie (Chief Financial Officer) disposed off 14,940 shares at an average price of $75.00 for $1.12 million. The insider now directly holds 103,916 shares of Hologic, Inc. (HOLX).
